Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 516

1.

Ionotropic glutamate receptor expression in human white matter.

Christensen PC, Samadi-Bahrami Z, Pavlov V, Stys PK, Moore GR.

Neurosci Lett. 2016 Sep 6;630:1-8. doi: 10.1016/j.neulet.2016.07.030. Epub 2016 Jul 18.

PMID:
27443784
2.

Human mannose-binding lectin inhibitor prevents Shiga toxin-induced renal injury.

Ozaki M, Kang Y, Tan YS, Pavlov VI, Liu B, Boyle DC, Kushak RI, Skjoedt MO, Grabowski EF, Taira Y, Stahl GL.

Kidney Int. 2016 Jul 1. pii: S0085-2538(16)30202-2. doi: 10.1016/j.kint.2016.05.011. [Epub ahead of print]

PMID:
27378476
3.

Emetine Di-HCl attenuates Type 1 diabetes mellitus in mice.

Hudson LK, Dancho ME, Li J, Bruchfeld JB, Ragab AA, He MM, Bragg M, Lenaghan D, Quinn MD, Fritz JR, Tanzi MV, Silverman HA, Hanes WM, Levine YA, Pavlov VA, Olofsson PS, Roth J, Al-Abed Y, Andersson U, Tracey KJ, Chavan SS.

Mol Med. 2016 Jun 10;22. doi: 10.2119/molmed.2016.00082. [Epub ahead of print]

PMID:
27341452
4.

Intrahospital Transfer of Patients with Traumatic Brain Injury: Increase in Intracranial Pressure.

Trofimov A, Kalentiev G, Yuriev M, Pavlov V, Grigoryeva V.

Acta Neurochir Suppl. 2016;122:125-7. doi: 10.1007/978-3-319-22533-3_25.

PMID:
27165891
5.

Some features of information properties of holographic recording media based on a photoconducting carbazolyl-containing oligomer doped with an organic electron acceptor.

Davidenko NA, Davidenko II, Studzinsky SL, Pavlov VA, Mokrinskaya EV, Chuprina NG, Kravchenko VV.

Appl Opt. 2016 Apr 20;55(12):B31-5. doi: 10.1364/AO.55.000B31.

PMID:
27140127
6.

Blocked Enzymatic Etching of Gold Nanorods: Application to Colorimetric Detection of Acetylcholinesterase Activity and Its Inhibitors.

Saa L, Grinyte R, Sánchez-Iglesias A, Liz-Marzán LM, Pavlov V.

ACS Appl Mater Interfaces. 2016 May 4;8(17):11139-46. doi: 10.1021/acsami.6b01834. Epub 2016 Apr 21.

PMID:
27070402
7.

Prevalence and risk factors for erectile dysfunction and lower urinary tract symptoms in Russian Federation men: analysis from a national population-based multicenter study.

Korneyev IA, Alexeeva TA, Al-Shukri SH, Bernikov AN, Erkovich AA, Kamalov AA, Kogan MI, Pavlov VN, Zhuravlev VN, Pushkar DY.

Int J Impot Res. 2016 Mar-Apr;28(2):74-9. doi: 10.1038/ijir.2016.8. Epub 2016 Feb 11.

PMID:
26865104
8.

[MARKERS OF KIDNEY DAMAGE AND NEPHROPROTECTIVE THERAPY IN RADICAL CYSTECTOMY].

Pavlov VN, Pushkarev AM, Kondratenko YV, Safiullin RI, Alekseev AV.

Urologiia. 2015 Sep-Oct;(5):27-30. Russian.

PMID:
26859933
9.

[ASSESSMENT OF ENERGY NEEDS AND THE ROLE OF NUTRITIONAL SUPPORT IN SENILE PATIENTS WITH INTESTINAL FAILURE IN ORTHOPEDIC SURGERY OF HIGH RISK].

Kirilina SI, Sirota VS, Pervukhin SA, Prokhorenko VM, Pavlov VV, Baitov VS.

Adv Gerontol. 2015;28(2):316-20. Russian.

PMID:
26856094
10.

Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients.

Louvel G, Metellus P, Noel G, Peeters S, Guyotat J, Duntze J, Le Reste PJ, Dam Hieu P, Faillot T, Litre F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes JR, Barat JL, Langlois O, Menei P, Dumont SN, Zanello M, Dezamis E, Dhermain F, Pallud J; Club de Neuro-Oncologie of Société Française deNeurochirurgie.

Radiother Oncol. 2016 Jan;118(1):9-15. doi: 10.1016/j.radonc.2016.01.001. Epub 2016 Jan 11.

PMID:
26791930
11.

[CONSTRUCTION AND PROPERTIES OF THE FRANCISELLA TULARENSIS VACCINE STRAIN WITHOUT ONE COPY OF THE IGLC GENE AND WITHOUT RECA GENE].

Mokrievich AN, Vakhrameeva GM, Titareva GM, Bakhteeva IV, Mironova RI, Kombarova TI, Kravchenko TB, Dyatlov IA, Pavlov VM.

Mol Gen Mikrobiol Virusol. 2015;33(3):33-9. Russian.

PMID:
26665740
12.

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.

Chanan-Khan A, Cramer P, Demirkan F, Fraser G, Silva RS, Grosicki S, Pristupa A, Janssens A, Mayer J, Bartlett NL, Dilhuydy MS, Pylypenko H, Loscertales J, Avigdor A, Rule S, Villa D, Samoilova O, Panagiotidis P, Goy A, Mato A, Pavlovsky MA, Karlsson C, Mahler M, Salman M, Sun S, Phelps C, Balasubramanian S, Howes A, Hallek M; HELIOS investigators.

Lancet Oncol. 2016 Feb;17(2):200-11. doi: 10.1016/S1470-2045(15)00465-9. Epub 2015 Dec 5.

PMID:
26655421
13.

Neural circuitry and immunity.

Pavlov VA, Tracey KJ.

Immunol Res. 2015 Dec;63(1-3):38-57. doi: 10.1007/s12026-015-8718-1.

PMID:
26512000
14.

5-Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Surgery of High-Grade Gliomas: A Systematic Review.

Guyotat J, Pallud J, Armoiry X, Pavlov V, Metellus P.

Adv Tech Stand Neurosurg. 2016;(43):61-90. doi: 10.1007/978-3-319-21359-0_3. Review.

PMID:
26508406
15.

Biocatalytic etching of semiconductor cadmium sulfide nanoparticles as a new platform for the optical detection of analytes.

Grinyte R, Saa L, Garai-Ibabe G, Pavlov V.

Chem Commun (Camb). 2015 Dec 14;51(96):17152-5. doi: 10.1039/c5cc05613f.

PMID:
26456861
16.

Photoelectrochemical detection of enzymatically generated CdS nanoparticles: Application to development of immunoassay.

Barroso J, Saa L, Grinyte R, Pavlov V.

Biosens Bioelectron. 2016 Mar 15;77:323-9. doi: 10.1016/j.bios.2015.09.043. Epub 2015 Sep 25.

PMID:
26432195
17.

[The Role of MiRNAs in the Development of Prostate Cancer].

Kunsbaeva GB, Gilyazova IR, Pavlov VN, Khusnutdinova EK.

Genetika. 2015 Jul;51(7):737-53. Review. Russian.

PMID:
26410927
18.

[PELVIC FLOOR RECONSTRUCTION AFTER PELVIC EVISCERATION USING GRACILIS MUSCULOCUTANEOUS FLAP].

Pavlov VN, Bakirov AA, Kabirov IR, Izmajlov AA, Kutlijarov LM, Safiullin RL, Urmancev MF, Sultanov IM, Abdrahimov RV.

Urologiia. 2015 May-Jun;(3):39-42. Russian.

PMID:
26390558
19.

Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Non-Obese Diabetic Mice.

Hanes WM, Olofsson PS, Kwan K, Hudson LK, Chavan SS, Pavlov VA, Tracey KJ.

Mol Med. 2015 Aug 17. doi: 10.2119/molmed.2015.00142. [Epub ahead of print]

20.

Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

Offner F, Samoilova O, Osmanov E, Eom HS, Topp MS, Raposo J, Pavlov V, Ricci D, Chaturvedi S, Zhu E, van de Velde H, Enny C, Rizo A, Ferhanoglu B.

Blood. 2015 Oct 15;126(16):1893-901. doi: 10.1182/blood-2015-03-632430. Epub 2015 Jul 31.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk